Glaukos (GKOS) financial statements

Healthcare · Medical Devices · Market cap $9.9B

Glaukos reported revenue of $507M in fiscal 2025, up 18.0% a year over 9 years.

Net income was -$188M and the operating margin -39.3%, against 3.7% in 2016.

Free cash flow was -$22M.

The diluted share count rose 57% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.200.20.40.62016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Glaukos's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$114M$159M$181M$237M$225M$294M$283M$315M$383M$507M
Cost of revenue$16M$21M$25M$39M$92M$67M$69M$76M$94M$112M
Gross profit$98M$138M$156M$198M$133M$227M$214M$239M$289M$283M
Research and development$29M$39M$50M$68M$85M$101M$123M$139M$136M$151M
Selling, general and admin$65M$96M$120M$177M$171M$179M$193M$224M$261M$332M
Operating income$4M-$2M-$13M-$50M-$124M-$33M-$82M-$129M-$122M-$200M
Interest expense———$3M$14M$13M$14M$14M$10M$5M
Pre-tax income$5M$1,000-$12M-$50M-$132M-$49M-$98M-$134M-$146M-$193M
Income tax$43,000$93,000$583,000-$65M-$12M$326,000$766,000$934,000$771,000-$5M
Net income$5M-$92,000-$13M$15M-$120M-$50M-$99M-$135M-$146M-$188M
EPS (diluted)$0.12$0.00-$0.37$0.37-$2.70-$1.07-$2.09-$2.78-$2.77-$3.28
Diluted shares36M34M35M41M44M46M47M48M53M57M
Gross margin85.9%86.8%86.2%83.7%59.2%77.3%75.6%76.0%75.5%55.7%
Operating margin3.7%-1.4%-7.2%-21.2%-54.9%-11.2%-29.1%-40.9%-31.9%-39.3%
Net margin4.0%-0.1%-7.1%6.5%-53.5%-16.9%-35.1%-42.8%-38.2%-37.0%

Balance sheet

Fiscal years, from Glaukos's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$96M$119M$149M$183M$414M$424M$120M$93M$170M$91M
Receivables$14M$17M$19M$38M$36M$33M$36M$40M$61M$109M
Inventory$7M$11M$13M$43M$16M$23M$38M$42M$58M$64M
Total current assets$120M$149M$177M$263M$469M$486M$444M$395M$450M$475M
Property, plant and equipment$8M$12M$19M$22M$24M$69M$94M$103M$98M$113M
Goodwill———$66M$66M$66M$66M$66M$66M$67M
Total assets$134M$166M$207M$818M$1.0B$1.0B$1.0B$940M$975M$893M
Total current liabilities$17M$27M$30M$58M$50M$63M$72M$74M$75M$101M
Total liabilities$17M$28M$33M$145M$338M$463M$472M$479M$208M$237M
Shareholders' equity$117M$138M$174M$673M$667M$587M$530M$462M$767M$656M
Net debt-$6M-$25M-$30M-$62M-$97M-$101M-$120M-$93M-$170M-$91M

Cash flow

Fiscal years, from Glaukos's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow$12M$26M$19M-$369,000-$23M$25M-$33M-$58M-$61M-$15M
Capital spending$6M$6M$10M$5M$7M$48M$30M$20M$6M$8M
Free cash flow$6M$20M$9M-$5M-$30M-$23M-$63M-$78M-$68M-$22M
Stock-based compensation$9M$18M$26M$36M$46M$30M$39M$44M$50M$63M
Net borrowing————$288M—————
Free cash flow margin5.3%12.4%4.7%-2.1%-13.3%-7.8%-22.4%-24.8%-17.6%-4.4%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for GKOS.
Open GKOS in Investingly

Questions

What was Glaukos's revenue in 2025?

$507M in fiscal 2025, from its 10-K filing.

How much free cash flow does Glaukos generate?

-$22M in fiscal 2025 (operating cash flow minus capital spending).

From Glaukos's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.